Interventional mental health and ketamine infusion therapies represent breakthrough treatment modalities that carry rigorous regulatory, controlled substance, and liability challenges. Because ketamine is a DEA Schedule III medication, clinics delivering intravenous, intramuscular, or sublingual treatments must operate under strict physician oversight, precise storage safeguards, and comprehensive emergency readiness. Furthermore, psychiatric mid-level providers (PMHNPs) frequently require dedicated collaborating psychiatrists with active state licenses and DEA registrations. Access Plus Health provides board-certified psychiatrists and medical directors who establish compliant clinical administration protocols, patient monitoring guidelines, and psychiatric contraindication screenings. We ensure your practice complies with the Ryan Haight Act, state medical board anesthesia guidelines, and DEA record-keeping mandates. Whether delivering in-clinic infusions or virtual mental health consultations, our directorship solutions provide the medical credibility and legal foundation necessary for safe patient care.